Gain Therapeutics (GANX) Operating Leases (2020 - 2026)
Gain Therapeutics (GANX) posted quarterly Operating Leases of $182129.0 for Q1 2026, up 495.41% year-over-year from $30589.0 in Q1 2025, and down 13.78% quarter-over-quarter from $211238.0 in Q4 2025.
Gain Therapeutics (GANX) Operating Leases (2020 - 2026) Analysis & Trends
Gain Therapeutics' Operating Leases history runs 7 years deep, the most recent figure standing at $182129.0 for Q1 2026.
- In Q1 2026, Operating Leases rose 495.41% year-over-year to $182129.0; the TTM figure through Mar 2026 stood at $182129.0 (up 495.41% YoY), while the FY2025 annual figure was $211238.0, up 294.12% from the prior year.
- Operating Leases for Q1 2026 stood at $182129.0, down from $211238.0 in the prior quarter.
- The five-year high for Operating Leases was $625449.0 in Q1 2022, with the low at $30589.0 in Q1 2025.
- The 5-year median for Operating Leases is $229855.0 (2023), against an average of $266939.6.
- The sharpest annual moves came in 2025 and 2026: Operating Leases tumbled 91.99% in 2025, then surged 495.41% in 2026.
- Gain Therapeutics' Operating Leases stood at $441784.0 in 2022, then sank by 47.97% to $229855.0 in 2023, then sank by 76.68% to $53598.0 in 2024, then soared by 294.12% to $211238.0 in 2025, then dropped by 13.78% to $182129.0 in 2026.
- Business Quant data shows GANX's Operating Leases at $182129.0 in Q1 2026, $211238.0 in Q4 2025, and $65026.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.23 Bn | 132.38 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.97 Bn | 78.97 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn |
| 4 | Moderna | 59.88 Bn | 54.74 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.20 Bn | 37.11 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.69 Bn | 10.30 Bn | 668.28 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.16 Bn | 26.33 Bn | - |
| 10 | Gain Therapeutics | 87.47 Mn | 87.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 156,760.00 |
| Mar 31, 2026 | 182,129.00 |
| Dec 31, 2025 | 211,238.00 |
| Sep 30, 2025 | 65,026.00 |
| Jun 30, 2025 | 92,851.00 |
| Mar 31, 2025 | 30,589.00 |
| Dec 31, 2024 | 53,598.00 |
| Sep 30, 2024 | 96,222.00 |
| Jun 30, 2024 | 134,321.00 |
| Mar 31, 2024 | 381,934.00 |
| Dec 31, 2023 | 229,855.00 |
| Sep 30, 2023 | 263,460.00 |
| Jun 30, 2023 | 330,071.00 |
| Mar 31, 2023 | 385,922.00 |
| Dec 31, 2022 | 441,784.00 |
| Sep 30, 2022 | 468,760.00 |
| Jun 30, 2022 | 544,765.00 |
| Mar 31, 2022 | 625,449.00 |
| Dec 31, 2021 | 695,053.00 |
| Sep 30, 2021 | 576,456.00 |